27 related articles for article (PubMed ID: 8137643)
1. Oral and intrauterine progestogens for atypical endometrial hyperplasia.
Luo L; Luo B; Zheng Y; Zhang H; Li J; Sidell N
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009458. PubMed ID: 30521671
[TBL] [Abstract][Full Text] [Related]
2. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
3. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Wheeler DT; Bristow RE; Kurman RJ
Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
[TBL] [Abstract][Full Text] [Related]
4. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
[TBL] [Abstract][Full Text] [Related]
5. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
Ushijima K; Yahata H; Yoshikawa H; Konishi I; Yasugi T; Saito T; Nakanishi T; Sasaki H; Saji F; Iwasaka T; Hatae M; Kodama S; Saito T; Terakawa N; Yaegashi N; Hiura M; Sakamoto A; Tsuda H; Fukunaga M; Kamura T
J Clin Oncol; 2007 Jul; 25(19):2798-803. PubMed ID: 17602085
[TBL] [Abstract][Full Text] [Related]
6. Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
Yu M; Yang JX; Wu M; Lang JH; Huo Z; Shen K
Fertil Steril; 2009 Dec; 92(6):2122-4. PubMed ID: 19591991
[TBL] [Abstract][Full Text] [Related]
7. [Atypical hyperplasia and complex hyperplasia of endometrium in women of reproductive age].
Guo LN
Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):725-7, 760. PubMed ID: 8137643
[TBL] [Abstract][Full Text] [Related]
8. [Endometrial hyperplasias: histology, classification, prognostic significance and therapy].
Horn LC; Bilek K; Schnurrbusch U
Zentralbl Gynakol; 1997; 119(6):251-9. PubMed ID: 9312959
[TBL] [Abstract][Full Text] [Related]
9. Endometrial hyperplasia and the risk of progression to carcinoma.
Lacey JV; Chia VM
Maturitas; 2009 May; 63(1):39-44. PubMed ID: 19285814
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen and endometrial pathologies: a prospective study.
Seoud M; Shamseddine A; Khalil A; Salem Z; Saghir N; Bikhazi K; Bitar N; Azar G; Kaspar H
Gynecol Oncol; 1999 Oct; 75(1):15-9. PubMed ID: 10502419
[TBL] [Abstract][Full Text] [Related]
11. [Endometrial hyperplasia--diagnosis and treatment].
Tropé CG; Marth C; Scheistrøen M; Abeler VM
Tidsskr Nor Laegeforen; 1999 May; 119(14):2030-4. PubMed ID: 10394278
[TBL] [Abstract][Full Text] [Related]
12. [Fertility sparing management of endometrial adenocarcinoma and atypical hyperplasia: a literature review].
Koskas M; Yazbeck C; Walker F; Delorme P; Azria E; Luton D; Madelenat P
Bull Cancer; 2012 Jan; 99(1):51-60. PubMed ID: 22212645
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]